Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in two upcoming investor conferences. Details are as follows:
A webcast of the company’s presentation will be available on the Events page, located within the Investors section of Checkpoint’s website, https://ir.checkpointtx.com/event-calendar/default.aspx, for approximately 30 days after the meeting.
Mr. Oliviero will be presenting a corporate update at the H.C. Wainwright 23rd Annual Global Investment Conference and will be available for one-on-one meetings during both conferences.
About Checkpoint Therapeutics
Investor Relations Contact:
Media Relations Contact:
Face the Music: The New Age of Bluetooth
Brunch Served in ITEXPO #TECHSUPERSHOW Expo Hall
WiFi6: Securing the Remote Future